ARTHROSI SECURES $75M IN SERIES D FINANCING

/PRNewswire/ -- Arthrosi Therapeutics, a clinical-stage biotechnology company, today announced the successful securing of $75 million in Series D financing....

Related Keywords

Hong Kong ,San Diego ,California ,United States ,China ,Shenzhen ,Guangdong ,Litain Yeh ,Shunqi Yan ,Hanxiong Li ,Apichope Pharmaceuticals ,Industry Hong Kong Co ,Shenzhen Stock Exchange ,Reichstein Biotech Hk Co ,Arthrosi Therapeutics Inc ,Reichstein Biotech ,Hope Pharmaceutical ,